UnknownNot Applicable

An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China

China2,000 participantsStarted 2015-07-01

Plain-language summary

This is a multi-omics research of Chinese cardiomyopathies patients, aiming to determine genetic risk factor and serial biomarkers of cardiomyopathies in diagnosis and prognosis.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Subjects who was diagnosed as cardiomyopathy by medical history, clinical symptoms, laboratory tests including ECG, echocardiography.
. Subject understands study requirements aand agrees to sign an informed consent form prior to any study procedures.

Exclusion criteria

. Endocrine disease known to cause heart muscle disease (including infants of diabetic mothers)
. History of rheumatic fever
. Toxic exposures known to cause heart muscle disease (anthracyclines, mediastinal radiation, iron overload or heavy metal exposure)
. HIV infection or born to an HIV positive mother
. Kawasaki disease
. Immunologic disease
. Uremia, active or chronic
. Abnormal ventricular size or function that can be attributed to intense 9.physical training or chronic anemia

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The primary objective of this study is to determine whether variation in genetic background or differentially expressed molecules influences clinical outcomes in cardiomyopathy.

Timeframe: Five year

Trial details

NCT IDNCT03076580

SponsorBeijing Institute of Heart, Lung and Blood Vessel Diseases

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-07-01

Contact for this trial

Jie Du, PhD

jiedubj@126.com

View on ClinicalTrials.gov More Dilated Cardiomyopathy trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Subjects who was diagnosed as cardiomyopathy by medical history, clinical symptoms, laboratory tests including ECG, echocardiography.
. Subject understands study requirements aand agrees to sign an informed consent form prior to any study procedures.

Exclusion criteria

. Endocrine disease known to cause heart muscle disease (including infants of diabetic mothers)
. History of rheumatic fever
. Toxic exposures known to cause heart muscle disease (anthracyclines, mediastinal radiation, iron overload or heavy metal exposure)
. HIV infection or born to an HIV positive mother
. Kawasaki disease
. Immunologic disease
. Uremia, active or chronic
. Abnormal ventricular size or function that can be attributed to intense 9.physical training or chronic anemia